The Role of Vitamin A in Retinal Diseases
Open accessThe DOI matches its Crossref record; 203 of the 216 references it cites were found in a registry or an index; 166 of the 321 sources its claims cite were checked for support.
Abstract
Review of diseases directly or indirectly connected with vitamin A pathways in the retina, pathophysiology and interventions.
Overview
CoChat Summary
## TL;DR
This review summarizes how vitamin A metabolism supports retinal function and how disruptions in that pathway contribute to retinal disease. It also reviews therapeutic attempts, noting that vitamin A supplementation can help in deficiency-related night blindness but is not routinely advised for most reviewed retinal disorders, and should be avoided in STGD1/ABCA4-retinopathy.
## Key findings
- Vitamin A is essential for visual phototransduction; 11-cis-retinal is isomerized to all-trans-retinal and then recycled through the visual cycle, and faults in this machinery can reduce visual detection and promote toxic retinal byproducts.
- Vitamin A deficiency causes retinal dysfunction that is reversible with supplementation, with rods affected first, producing night blindness, followed by cone dysfunction and daytime vision impairment.
- ABCA4-retinopathy (Stargardt disease/STGD1) is the most frequent single-gene retinal dystrophy, affecting approximately 1 in 8000–10,000 individuals worldwide; high vitamin A intake is thought to be a risk factor for progression, so patients are discouraged from taking vitamin A supplements.
- In RPE65-related disease, pathogenic variants account for approximately 3% to 16% of LCA/EOSRD patients; an open-label, prospective, multi-center, phase 1b trial of oral QLT091001 in patients with defective RPE65 and LRAT showed improved vision, but some patients had headaches, photophobia, nausea, and changes in serum lipids and liver enzymes.
- In RP, a clinical trial reported that 15,000 IU/day vitamin A (as retinyl palmitate) slowed decline in 30-Hz ERG amplitude versus no such dose (p < 0.001) in 601 patients aged 18–49 years over 4 to 6 years.
## Methods
- Narrative review of vitamin A biology in the retina and retinal diseases directly or indirectly associated with vitamin A pathways, with a separate summary of relevant clinical trials.
- The paper draws on previously published clinical studies, animal studies, and ongoing registered trials (for example, NCT numbers are listed in the text).
- Main analysis is descriptive/synthesizing: it organizes diseases by mechanism (vitamin A deficiency, visual-cycle gene defects, and local deficiency) and summarizes pathophysiology, clinical presentation, and treatment attempts.
## Limitations
- The paper is a review, so it does not present new original patient-level data or a systematic meta-analysis; this is evident from the text.
- The authors note that routine vitamin A administration is not currently advised for many reviewed patients and that further studies are needed on vitamin A metabolism and treatment effects.
- The paper explicitly states that many therapies are still under investigation, that no therapy has yet been registered for some approaches, and that some treatments are limited by potential toxicity or side effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
88 Valid · 4 Not valid · 26 Not checked · 10 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Pathogenic variants in the RLBP1 gene prevent regeneration of 11-cis-retinal, which leads to reduced autofluorescence signal [87,159].”
§ The Role of Vitamin A in Retinal Diseases > 2. Retinal Diseases Directly or Indirectly Associated with Vitamin A and Its Pathways > 2.2. Retinal Diseases Associated with Pathogenic Variants in Genes Encoding Proteins Involved with Visual Cycle or Phototransduction
What the sources say
- Partly supportedcites [87] Oh, 2020, Short-Wavelength and Near-Infrared Autofluorescence in Patients with Deficiencies of the Visual Cycle and Phototransduction, Sci. Rep. sourceExperimental — accuracy not yet measured
The Introduction links RLBP1 to production of 11-cis-retinal, and the Discussion reports reduced autofluorescence in patients with visual-cycle gene mutations. But the Discussion explicitly says that with RLBP1 mutations, 11-cis-retinal can still be produced at reduced efficiency; the variants do not prevent its regeneration entirely. (LLM, conf=0.90)
- Disputedcites [159] Kim, 2020, Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion explicitly says CRALBP deficiency does not block production of 11-cis-retinoid: 11-cis-retinal is regenerated at a slower rate, contrary to the claim that pathogenic variants prevent regeneration. The Discussion also supports the reduced-autofluorescence part, attributing lower qAF to reduced availability of the visual chromophore. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Lipofuscin cannot form as a result of a non-functional visual cycle [115,116,117].”
§ The Role of Vitamin A in Retinal Diseases > 2. Retinal Diseases Directly or Indirectly Associated with Vitamin A and Its Pathways > 2.2. Retinal Diseases Associated with Pathogenic Variants in Genes Encoding Proteins Involved with Visual Cycle or Phototransduction
What the sources say
- Not checked — no full text of the sourcecites [115] Lorenz, 2004, Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65, Ophthalmology source
- Disputedcites [116] Kumaran, 2020, Retinal Structure in RPE65-Associated Retinal Dystrophy, Investig. Ophthalmol. Vis. Sci. sourceExperimental — accuracy not yet measured
The Results > Discussion passage (page unavailable) reports central autofluorescence in 46% of subjects with RPE65-associated retinal dystrophy and says it could indicate lipofuscin accumulation. That runs contrary to the categorical claim that lipofuscin cannot form, although the paper does not directly measure visual-cycle function or confirm that the fluorescence is lipofuscin. (LLM, conf=0.77)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [117] Katz, 2001, Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium, Investig. Ophthalmol. Vis. Sci.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“One of the most important vitamin A functions is its involvement in visual phototransduction, where it serves as the crucial part of photopigment, the first molecule in the process of transforming photons of light into electrical signals.”
§ The Role of Vitamin A in Retinal Diseases > Abstract
What the sources say
- Supportedcites [1] Carazo, A., Macáková, K., Matoušová, K., Krčmová, L.K., Protti, M., and Mladěnka, P. (2021). Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity. Nutrients, 13. source
Section 4.1, “Vision,” identifies 11-cis-retinal as the vitamin A derivative that combines with opsin to form rhodopsin, the crucial pigment for light perception. It says light transforms 11-cis-retinal and initiates the reaction chain that transmits visual perception to the brain. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [2] Blaner, 2016, Vitamin A Absorption, Storage and Mobilization, Subcell Biochem. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Therefore, for treatment of age-related macular degeneration (AMD), the original Age-Related Eye Disease Study (AREDS) formulation that included beta-carotene was replaced with the AREDS2 formula, where beta-carotene was substituted with lutein and zeaxanthin [23].”
§ The Role of Vitamin A in Retinal Diseases > 1. Introduction > 1.2. Hypervitaminosis A
What the sources say
- Partly supportedcites [23] Chew, 2014, Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3, JAMA Ophthalmol. sourceExperimental — accuracy not yet measured
The Interventions section identifies beta-carotene in the original AREDS formulation, and the Lutein/zeaxanthin vs. Beta-carotene section compares it with a formulation containing lutein/zeaxanthin instead. But the Conclusion and Relevance section says only that lutein/zeaxanthin *could* be more appropriate; it does not establish that the original formulation was definitively replaced. Page numbers are not available in our copy. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In this process, large quantities of vitamin A in the form of 11-cis-retinal are being isomerized to all-trans-retinal and then quickly recycled back to 11-cis-retinal.”
§ The Role of Vitamin A in Retinal Diseases > Abstract
What the sources say
- Partly supportedcites [29] Perusek, 2013, Vitamin A derivatives as treatment options for retinal degenerative diseases, Nutrients sourceExperimental — accuracy not yet measured
The Figure 2 caption in §3.1 describes light-induced isomerization of 11-cis-retinal to all-trans-retinal and its regeneration through the visual cycle. The paper does not establish that large quantities are recycled quickly in general: §3.2 describes rapid recycling specifically in cones and says it is faster than in rods. (LLM, conf=0.84)
- Partly supportedcites [32] Harrison, 2019, Mechanisms of Transport and Delivery of Vitamin A and Carotenoids to the Retinal Pigment Epithelium, Mol. Nutr. Food Res. sourceExperimental — accuracy not yet measured
The Introduction (Sec. 1) supports the isomerization step — 'Upon absorption of light, the 11-cis retinaldehyde isomerizes to all-trans retinaldehyde' — and Sec. 4.1 (Uptake and Metabolism of Retinol in the RPE) supports the recycling limb, describing all-trans retinol being shuttled by IRBP to the RPE, esterified by LRAT, isomerized by RPE65 to 11-cis retinol and oxidized by RDH5 to 11-cis retinaldehyde for delivery back to the rod outer segments. However, no passage in our copy (searched: 'large quantities', 'rate of regeneration', 'continuously', 'amount of vitamin A in vision') states the magnitude qualifier 'large quantities' of vitamin A involved in phototransduction, nor characterises the recycle as 'quick'; the only efficiency statement concerns STRA6-mediated retinol uptake into the RPE, not cycle speed. Our copy also has the species returning to the RPE as all-trans retinol rather than all-trans-retinal as the claim words it. (LLM, conf=0.72)
- Partly supportedcites [46] Kiser, 2012, Key enzymes of the retinoid (visual) cycle in vertebrate retina, Biochim. Biophys. Acta sourceExperimental — accuracy not yet measured
The Abstract and Introduction (page not provided) describe photoisomerization of 11-cis-retinal to all-trans-retinal and its regeneration through the retinoid cycle. The Introduction also describes high retinoid flux during intense light exposure, but does not establish that recycling back to 11-cis-retinal is quick. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
52 more claims · 34 with their cited sources checked
Create a free account to see all 128 claims and to verify the 59 references still open.
- It may state two separate claims as one. 58
- Probably not a substantial claim. 30
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Role of Vitamin A in Retinal Diseases > 2. Retinal Diseases Directly or Indirectly Associated with Vitamin A and Its Pathways > 2.2. Retinal Diseases Associated with Pathogenic Variants in Genes Encoding Proteins Involved with Visual Cycle or Phototransduction
“RHD8 is located on chromosome 19p13.2, while RDH12 locates on chromosome 14q24.1.”
§ The Role of Vitamin A in Retinal Diseases > 2. Retinal Diseases Directly or Indirectly Associated with Vitamin A and Its Pathways > 2.2. Retinal Diseases Associated with Pathogenic Variants in Genes Encoding Proteins Involved with Visual Cycle or Phototransduction
“RDH8 is located in the outer segment of cones and rods, while RDH12 is in the inner segments of cones and rods.”
Citations
Cites
Items 201–203 of 203
Bernal, S., Calaf, M., Adán, A., Solans, T. T., Valverde, D., Ayuso, C., & Baiget, M. (2001) · Ophthalmic Genetics · doi:10.1076/opge.22.1.19.2237 · Cited by 5
Kowe, P., Wankhade, V., Kulkarni, M., et al. (2020) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_535_19 · Cited by 2 · cited 1×
“Dermatologic manifestations include generalized xerosis and follicular hyperkeratosis, with patients exhibiting dry, rough and peeling skin [1,10,12,24].”
BackgroundSyndromic Microphthalmia 9: Role of rapid genome sequencing and novel mutations in STRA6 gene
Saini, A., Almasarweh, S., Acosta, S., Jayakar, P., Janvier, M., Wong, T. C., Salyakina, D., & Sasaki, J. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101443 · Cited by 1
Research works printed but not linked: 1
- Said, H.M. (2018). Chapter 50—Digestion and Intestinal A. Physiology of the Gastrointestinal Tract, Academic Press. [6th ed.].
Cited by
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies
Nguyen, X., Moekotte, L., Plomp, A. S., Bergen, A. A. B., van Genderen, M. M., & Boon, C. J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087481 · Cited by 150
“Currently, less than 10% of the genes in RP involve genes associated with vitamin A metabolism [342].”
BackgroundTalib, W. H., Jum'Ah, D., Attallah, Z. S., Jallad, M. S., Kury, L. T. A., Hadi, R. W., & Mahmod, A. I. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1281879 · Cited by 72
“Substances with a common structure of four isoprenoid subunits, whether of synthetic or natural origin, are also categorized as retinoids (69).”
BackgroundInfluentialBorchert, G. A., Shamsnajafabadi, H., Hu, M. L., Silva, S. R. D., Downes, S. M., MacLaren, R. E., Xue, K., & Cehajic‐Kapetanovic, J. (2023) · Cells · doi:10.3390/cells12162092 · Cited by 54
“It has been suggested that targeting the visual cycle, in which vitamin A has a central role, may be a further therapeutic approach [72].”
BackgroundVitamin A: too good to be bad?
Chen, G., Weiskirchen, S., & Weiskirchen, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1186336 · Cited by 65
“Based on the important functions of VA and diseases that are directly or indirectly connected with VA signaling pathways, this vitamin is intensively discussed as a therapeutic compound to cure various diseases (Chen et al., 2022; Cook et al., 2022; Sajovic et al., 2022; Zawada et al., 2023).”
BackgroundComander, J., Weigel-DiFranco, C., Sanderson, K., Place, E., Maher, M., Zampaglione, E., Zhao, Y., Huckfeldt, R. M., Bujakowska, K. M., & Pierce, E. A. (2023) · JCI Insight · doi:10.1172/jci.insight.167546 · Cited by 49
Metadata
- Authors
- Sajovic, J., Meglič, A., Glavač, D., Markelj, Š., Hawlina, M., & Fakin, A.
- Affiliations
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Corresponding author
- Fakin, Ana
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-18
- Volume
- 23
- Issue
- 3
- Pages
- 1014
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8835581
- OpenAlex
- W4205754721
- Cited by
- 109
- References
- 216
- Citations by year
- 2026: 30 · 2025: 31 · 2024: 23 · 2023: 22 · 2022: 3
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Slovenian research agency (ARRS J3-1750)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- vitamin A, retinal disease, phototransduction, 11-cis-retinal, all-trans-retinal, visual cycle, retinoids, vitamin A deficiency, vitamin A toxicity, retinal pigment epithelium, therapeutic interventions
- MeSH terms
- Gene Expression Regulation, Humans, Retinal Diseases, Vitamin A, Signal Transduction, Light Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.